CAG/CTG repeat expansions in genomic DNA of testicular tumour cell lines, and germline DNA from members of families predisposed to this malignancy, have been previously described. In order to identify genes possibly concerned by this alteration, we attempted to clone all possible human testis cDNA containing at least ®ve CAG/CTG repeats. Thirty-four dierent transcripts were identi®ed. By using PCR and non denaturing gel electrophoresis, we determined the size of their repeats, as well as their polymorphisms in a collection of human testicular germ cell tumours and the normal surrounding tissues. For all tested genes, we detected the presence of several species of the same mRNA for each person. Nine genes exhibited speci®c patterns of expression among dierent groups of individuals, indicative of polymorphism. None of these polymorphisms was related to human testicular tumours. Oncogene (2001) 20, 5548 ± 5553.
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Keywords: human testicular germ cell tumours; CAG/ CTG repeat expansion; genetic anticipation Testicular germ cell tumours are the most frequent solid malignant tumours in young adult men. These tumours, except spermatocytic seminoma, derive from an intratubular preinvasive lesion named carcinoma in situ (CIS) of the testis (Skakkebaek et al., 1987; Dieckmann and Skakkebaek, 1999) . The factors involved in the progression of CIS to testicular germ cell tumours remain unknown (Rajpert de Meyts E., 1998).
Expansion or contraction of short tandem repeat nucleotide sequences have been demonstrated in the DNA of several tumours occurring in hereditary nonpolyposis colorectal cancer, sporadic carcinomas of the colon, breast, stomach, lung, bladder, endometrium and oesophagus (Debrauwere et al., 1997; Schmutte and Fishel, 1999; Wooster et al., 1994; Liu et al., 1996; Eshleman and Markowitz, 1995) . Among the dierent types of repeats, CAG/CTG alterations have been described in prostate and ovarian tumours as well as in uterine endometrial carcinoma (Giovannucci et al., 1997; Stanford et al., 1997; Kinoshita et al., 1997; Sasaki et al., 2000) .
Recently, using Rapid Expansion Detection (RED), King et al. detected an increase of the CAG/CTG repeat number in genomic DNA from human testicular tumour cell lines, as well as in germline DNA from members of ®ve testicular cancer families as compared to the normal population (King et al., 1997) . Since RED does not provide information on the locus of the ampli®ed repeat, we wanted to determine whether one or several genes containing such repeat were altered in testis tumours.
Since CAG/CTG ampli®cations have been always described in the transcribed part of the gene, we screened 4610 6 clones of a human testis cDNA library using a (CAG) 14 oligonucleotide probe. We identi®ed 352 positive clones corresponding to 65 dierent genes (Bulle et al., 1997; Pawlak et al., 1998) . Among them, 32 contained more than four CAG/CTG repeats which were framed by sequences allowing the design of primers for further ampli®cation. In addition, the screening of 40 000 human testis EST (dbEST database-NCBI) allowed to identify two additional genes which were added to our series. Altogether, we considered 34 transcripts (Table 1) which are likely to represent an almost complete population of genes containing more than four CAG/CTG repeats and expressed in human testis.
Using the program PCR base (Infobiogen), we designed sets of primers framing CAG/CTG repeats in the sequence of these selected genes. These primers had the following characteristics: (i) a size ranging from 18 to 23 mer; (ii) a melting temperature (Tms) around 45 ± 488C; (iii) the presence of a GC clamp at the 3' end of the oligonucleotide whenever possible; (iv) the absence of a stable internal secondary structure in the oligonucleotide; (v) the lack of complementary sequence between the two primers; (vi) the size of ampli®ed sequences between 200 ± 300 bp; and (vii) they do not match to other sequences present in the public databases. All sets of primers have been deposited in dbSTS database under accession numbers G64266 to G64299.
Since repeat instability associated with cancer usually exhibited small changes in repeat number and relatively equal incidence of insertion and deletion mutations (Wooster et al., 1994) , we ran the PCR product on a non-denaturing polyacrylamide gel using a method similar to the HD-PCR (Nataraj et al., 1999; Panagopoulos et al., 1999) . Such a migration permits the detection of variations in repeats number among dierent PCR fragments as well as point mutation occurring in the repeat of one allele of the analysed genes, by forming heteroduplexes.
A preliminary screening of the candidate genes was performed by the ampli®cation of the corresponding transcripts in pooled mRNA samples from seminomas, teratomas, combined tumours, and the three groups of surrounding normal tissues respectively, as well as, three samples from human normal testes. Among the ampli®cations of the 34 mRNA sequences, one failed and 24 generated identical pattern with several bands for all tested samples. The RT ± PCR patterns obtained for three transcripts are depicted in Figure 1 : (i) the nucleolar phosphoprotein p130, with a band at 287 bp expected from the cDNA sequence and three additional bands of 400, 520 and 650 bp; (ii) the H1 chloride channel, with the expected band (186 bp) as well as three additional bands at 270, 420 and 470 bp; and (iii) the IFN-responsive transcription factor, with a band at the expected size (237 bp) and two additional bands (340 and 470 bp). No dierence was observed between the tumour tissues and control tissues.
Nine mRNAs out of the 34 analysed mixed samples generated several bands which varied in size and number among the dierent individuals. These mRNA encode the MJD1 protein (Kawaguchi et al., 1994) , the myotonin protein kinase (Fu et al., 1992) , the TATA binding protein (Peterson et al., 1990) , the CTG-B33 clone (Li et al., 1993) , the CTG-B10 clone (Li et al., 1993) , the ataxin-2 (Pulst et al., 1996) , the CAG-H1 (Margolis et al., 1997) , the MHC class1 polypeptide related sequence A (Bahram et al., 1994) and the androgen receptor (Lubahn et al., 1988) (Table 1) .
We analysed the expression of these nine genes in individual samples from pathological and normal tissues. Data obtained for the MJD1 protein, the CTG-B10 and the androgen receptor are representative of the results obtained for this group of nine genes. The blots of the ampli®ed products were hybridized with a (CAG) 14 speci®c probe (data not shown) and with a probe speci®c for each ampli®ed fragment (Figure 2 ). Both hybridizations gave exactly the same pattern. Only the hybridizations with the speci®c probe are shown in this paper.
RT ± PCR products of MJD1 mRNA displayed a complex pattern with several bands ranging from 190 to 400 bp, in all tested samples including controls (Figure 2a) . For a single individual, the same pattern The analysis of the CAG/CTG repeats present in CTG B10 mRNA revealed the expected band at 218 bp in all samples. Larger bands, ranging from 180 to 400 bp, were observed giving rise to three distinct patterns: (A) eight bands (180, 218, 240, 250, 260, 310, 360 and 390 bp) for two seminomas (1,3), two combined tumours (8 and 9) and the three normal testes (a,b and c); (B) six bands (180, 218, 290, 310, 370 and 390 bp), for one seminoma (2) and two teratomas (4 and 5); and (C) six bands (180, 218, 240, 260, 310 and 370 bp) for the two remaining combined tumours (6 and 7) (Figure 2b) . In all cases, tumours and the surrounding normal tissues always display the same pro®le.
The androgen receptor mRNA exhibits the ampli®ed expected band (251 bp) except for two seminomas (1 and 2) and a normal individual (a) who displayed bands at 225, 235, and 260 bp, respectively. Three larger bands (315, 325 and 420 bp) were observed in all samples (Figure 2c) . Furthermore, the ampli®ed products were less abundant in all tumour samples as compared to the surrounding tissues.
These patterns were not speci®c for testes, since the synthesis and migration of PCR products from liver generated similar pro®les as the ones obtained in testes (Figure 3) .
In order to determine whether these complex patterns resulted from heteroduplex formation, we analysed the ampli®ed products for MJD1, CTG-B10 and androgen receptor on a denaturing polyacrylamide gel. We observed only two bands for the MJD1 mRNA and a single band for CTG-B10 and androgen receptor (Figure 4 ).
As for these three genes, for all tested genes in each sample, we observed additional bands as the one expected indicative of polymorphism. The presence of these heteroduplexes could signify: (i) a small variation of the number of CAG or CTG in the same messenger; and (ii) the presence of several messengers diering by small alterations such as mutations or small deletions/ insertions and encoded by one gene or several highly homologous genes from two or more genes. This polymorphism does not result from allelic mosaicism occurring during spermatogenesis since identical PCR product pro®les were observed in liver and testis (Telenius et al., 1995) . The complexity of the pattern did not correlate with the number of CAG/CTG repeats present in the mRNA sequence.
We did not observe any variation between pathological and normal samples for the 34 CAG/CTG containing genes that we analysed. These results do not support the initial observation of CAG/CTG repeat ampli®cation observed by King using the RED method (King et al., 1997) . Several possibilities might explain this discrepancy: (i) the expansion detected by RED occurs in an intronic or extragenic region. Until now, all CAG/CTG expansion/deletion have been reported either in the coding part of the genes as for the androgen receptor gene altered in spinobulbar muscular atrophy, prostate tumour or uterine endometrial carcinoma as well as for other genes involved in Huntington disease, Dentorubral-pallidoluysian atrophy, various spinocerebellar ataxias or in the non coding part of the transcript such as in Mytonic Dystrophy, ovarian tumours as well as, Spinocerebellar ataxia type 8 and 12 (Cummings and Zoghbi, 2000; Holmes et al., 1999; Giovannucci et al., 1997; Kinoshita et al., 1997; Sasaki et al., 2000) ; (ii) although we have tried to identify all possible gene containing Figure 1 Expression of the nucleolar phosphoprotein P130, H1 chloride channel, and IFN-responsive transcription factor genes on mixed RNA samples from dierent testicular tumours and controls. RT ± PCR were done on 10 ng pooled mRNA samples obtained from three seminomas, two teratomas or four combined tumours using Access RT ± PCR System (Promega). After migration on 8% non-denaturing acrylamide gel and blotting, the speci®c PCR products were revealed by using a (CAG)14 probe. *Indicates the position of the expected band for nucleolar phosphoprotein P130 (287 bp), H1 chloride channel (186 bp), and IFN responsive transcription factor (237 bp). T: tumour testis sample, C: surrounding normal part of the tumour sample used as control, N: normal testis sample. The number of samples are indicated in parenthesis. Na, Nb and Nc correspond to the three normal samples CAG/CTG repeats expressed in testis, we might have missed genes which were positive in the RED study;
(iii) the gene with an ampli®ed repeat detected by RED during tumorigenesis has less than ®ve CAG/CTG Figure 2 Expression of the MJD1 protein, CTG-B10, and androgen receptor genes on RNA samples from dierent testicular tumours and controls. RT ± PCR was performed on separated RNA samples obtained from three seminomas, two teratomas, four combined tumours or normal testes (a ± c). The speci®c PCR products were revealed by hybridization with a [ 32 P] oligonucleotide probe (5'-TTCAGAAGAGCTTCGGAAGAGACG-3') (nt 866 ± 889) or (5'-GCCAAGCTCCGGAATGTTGTCCTGG-3') (nt 235 ± 260) and (5'-ATGGTTCTCCCCAAGCCCATCGTAG-3') (nt 637 ± 661), speci®c of MJD1 protein, CTG-B10, and androgen receptor, respectively. *Indicates the expected bands for the genes MJD1 protein (a), CTG-B10 (b), and androgen receptor (c) with a size of 211, 218 and 251 bp respectively. T: tumour testis sample, C: surrounding normal part of the tumour sample used as control. N: normal testis sample repeats in normal testis. However, this has never been described for genes involved in diseases associated with CAG/CTG ampli®cation; (iv) the altered gene is silent in normal tissue and can only be detected in pathological samples; and ®nally (v), RED study concerns a very limited population of testis tumour cell lines and familial cancer and the observations cannot be generalized to all types of testis tumours.
Recently, Han et al. proposed genetic anticipation as one of the mechanisms involved in the pathogenesis of familial testicular cancer, based on an earlier age of clinical onset of the disease in sons in comparison to their fathers (Han et al., 2000) . One of the possible explanation to this phenomen could be instability and expansion of trinucleotide. Teh et al. also performed a RED analysis of CAG/CTG repeat in eight familial testicular cancers, but they did not detect any variation in the number of CAG/CTG repeat (Teh et al., 1999) . Altogether, these results argue for a lack of CAG/CTG expansion in gene expressed in human testis during carcinogenesis of sporadic or familial germ cell tumours. Figure 3 Comparison of transcript expressions of the MJD1 protein, CTG-B10, and androgen receptor genes in human testis and liver. RT ± PCR was carried out on RNA samples obtained from human testis (T) or liver (L) obtained from two unrelated individuals. After migration on a non-denaturing gel, the speci®c PCR products were revealed using a (CAG)14 probe. *Indicates the expected band for the gene MJD1 protein, CTG-B10, and androgen receptor corresponding to a size of 211, 218 and 251 bp respectively Figure 4 Migration under denaturing conditions on acrylamide gel of RT ± PCR products corresponding to the transcripts of MJD1 protein, CTG-B10, and androgen receptor expressed in normal testis. RT ± PCR was done on RNA samples obtained from a normal testis. The speci®c PCR products were loaded on an acrylamide gel under denaturing conditions (6M urea) and revealed using a (CAG) 14 probe
